CellGenix® rh IFN-γ
CellGenix Recombinant Human IFN-γ reliably promotes the maturation of monocyte-derived dendritic cells (Mo-DCs) and the generation of cytokine induced killer cells (CIK cells). It is produced in our dedicated animal-free facility ensuring maximum safety for optimal use in ATMP manufacturing.
Interferon-gamma (IFN-γ) is a cytokine that is critical for innate and adaptive immunity against viral, some bacterial and protozoal infections. It is the only member of the type II class of interferons and is predominantly produced by natural killer cells (NK cells) and T cells.
IFN-γ is used in the cell and gene therapy space for the ex vivo maturation of Mo-DCs, ex vivo generation of CIK cells and stimulation of monocytes, macrophages and microglia.
The final manufacturing steps and quality control of all our preclinical grade products are performed in a GMP facility ensuring a consistent high quality.
CellGenix® Recombinant Human Interferon-gamma
CellGenix® Preclinical rh IFN-γ
CellGenix® rh IFN-γ
- Produced in our dedicated animal-free facility
- High purity, activity and product stability
Expressed in E. coli
Human Interferon-gamma, accession # P01579, Gln24-Arg162
Lyophilized from a 0.2 µm-filtered solution containing 20 mM succinate, pH 5.0
Final manufacturing steps and Quality Control (QC) are performed in a GMP facility.
|Molecular weight||16.5 kDa|
|Purity||≥ 95% as determined by SDS-PAGE|
|Activity||≥ 10 x 106 IU/mg, calibrated against Imukin® Measured in a cell cytotoxicity assay using HT-29 cells|
|Endotoxin level||< 1000 EU/mg|
|Intended use||Intended for preclinical ex vivo use. Not intended for therapeutic use.|
Recommended in sterile water to a final concentration of 250 µg/ml.
Ambient temperature. Please refer to Technote to learn more about our shipment validation procedure.
3 years from date of shipment.
Storage & Stability
Store lyophilized cytokine at -20°C to -80°C.
Avoid repeated freeze/thaw cycles.